Alkermes plc (NASDAQ: ALKS) kicked off on Monday, up 1.69% from the previous trading day, before settling in for the closing price of $26.09. Over the past 52 weeks, ALKS has traded in a range of $21.75-$32.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 10.61%. While this was happening, its average annual earnings per share was recorded 82.83%. With a float of $158.76 million, this company’s outstanding shares have now reached $166.98 million.
The extent of productivity of a business whose workforce counts for 2100 workers is very important to gauge. In terms of profitability, gross margin is 82.22%, operating margin of 20.77%, and the pretax margin is 22.07%.
Alkermes plc (ALKS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Alkermes plc is 1.88%, while institutional ownership is 111.27%. The most recent insider transaction that took place on Mar 18 ’24, was worth 292,740. In this transaction SVP, Chief Commercial Officer of this company sold 10,417 shares at a rate of $28.10, taking the stock ownership to the 65,911 shares. Before that another transaction happened on Feb 27 ’24, when Company’s VP, Finance (Interim PAO) sold 2,559 for $29.65, making the entire transaction worth $75,874. This insider now owns 7,717 shares in total.
Alkermes plc (ALKS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 82.83% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Take a look at Alkermes plc’s (ALKS) current performance indicators. Last quarter, stock had a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.85. Likewise, its price to free cash flow for the trailing twelve months is 13.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.96, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 1.83 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
The latest stats from [Alkermes plc, ALKS] show that its last 5-days average volume of 2.97 million was superior to 1.85 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 17.37%. Additionally, its Average True Range was 0.96.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 55.34%, which indicates a significant increase from 17.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.69% in the past 14 days, which was higher than the 33.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.79, while its 200-day Moving Average is $26.56. Now, the first resistance to watch is $26.94. This is followed by the second major resistance level at $27.35. The third major resistance level sits at $27.87. If the price goes on to break the first support level at $26.01, it is likely to go to the next support level at $25.49. The third support level lies at $25.08 if the price breaches the second support level.
Alkermes plc (NASDAQ: ALKS) Key Stats
The company with the Market Capitalisation of 4.29 billion has total of 169,221K Shares Outstanding. Its annual sales at the moment are 1,663 M in contrast with the sum of 355,760 K annual income. Company’s last quarter sales were recorded 378,140 K and last quarter income was 92,380 K.
